Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Teruo KITANI"'
Autor:
Ichiro Konishi, Hirohiko Kuratsune, Yukihiro Tokumine, Takashi Machii, Shinichi Tagawa, Teruo Kitani
Publikováno v:
Scandinavian Journal of Haematology. 32:306-312
The leukaemic cells of 11 patients with Japanese adult T-cell leukaemia (ATL) were characterized in terms of phenotype employing various monoclonal antibodies against T-cell surface antigens. The leukaemic cells of all ATL patients except patient no.
Autor:
G. Bourikas, R. Gomez, M. Cherchi, Teruo Kitani, A. V. Hoffbrand, Melvyn Greaves, E. Matutes, A. Wechsler, M. B. Pepys, E. O. Pepys, Daniel Catovsky
Publikováno v:
Scandinavian Journal of Haematology. 29:398-404
Cells from 13 cases of T-prolymphocytic leukaemia (T-PLL) were studied with a battery of immunological techniques in order to define their membrane phenotype. All cases were E-rosette positive and were negative with OKT6, anti-HLA-DR, anti-Ig and M-r
Publikováno v:
Japanese Journal of Physical Fitness and Sports Medicine. 57:305-314
Autor:
Takashi Kageyama, Yoshiteru Konaka, Yukihiro Tokumine, Atsushi Horiuchi, Tadahiro Tsubakio, Hedeki Fujitake, Noriyuki Tatsumi, Kiyoyasu Nagai, Tohru Masaoka, Teruo Kitani, J. Kuyama, Machiko Tsukaguchi, Yonezawa T, Kunio Hayashi, Kaori Nasu, Hiroya Kawagoe, Eizo Kakishita
Publikováno v:
Journal of Clinical and Experimental Hematopathology. 45:71-79
We examined effects of combination chemotherapy with dexamethasone, melphalan, vincristine, and MCNU (DMVM), plus IFN-α in patients with previously untreated and treated multiple myeloma (MM). In the study, 78 previously untreated and 47 treated MM
Autor:
Etsuji Suehisa, Teruo Kitani, Yuzuru Kanakura, Hirohiko Kuratsune, Junzo Nojima, Yoshinori Iwatani
Publikováno v:
Thrombosis and Haemostasis. 91:967-976
SummaryCerebral infarction is the most common arterial thromboembolic complication in the anti-phospholipid antibodies (aPL) syndrome. In an effort to clarify the roles of aPL in the pathogenesis of cerebral infarction in patients with SLE, we examin
Autor:
Junzo Nojima, Teruo Kitani, Yuzuru Kanakura, Takashi Machii, Tomio Kawasaki, Etsuji Suehisa, Hirohiko Kuratsune, Yoshinori Iwatani
Publikováno v:
British Journal of Haematology. 118:577-583
Venous thromboembolism (VTE) is one of the common manifestations in the anti-phospholipid (aPL) syndrome. We examined the levels of IgG antibodies (Abs) to beta2-glycoprotein I (beta2-GP I) and prothrombin, lupus anticoagulant (LA) activity, activate
Autor:
Junzo Nojima, Yoshinori Iwatani, Teruo Kitani, Hirohiko Kuratsune, Yuzuru Kanakura, Tomio Kawasaki, Etsuji Suehisa, Takashi Machii
Publikováno v:
Thrombosis and Haemostasis. 88:716-722
SummaryAnti-phospholipid (aPL) antibodies (Abs) are well known to be associated with thromboembolic events in patients with systemic lupus erythematosus (SLE). However, the clinical relevance of aPL Abs in patients without SLE (non-SLE) who have veno
Autor:
Yoshinori Iwatani, Teruo Kitani, Yoshiaki Futsukaichi, Takashi Machii, Etsuji Suehisa, Hirohiko Kuratsune, Junzo Nojima, Hachiro Yamanishi, Yuzuru Kanakura
Publikováno v:
British Journal of Haematology. 114:647-654
Anti-prothrombin antibodies (anti-prothrombin) and anti-beta2-glycoprotein I antibodies (anti-beta2-GP I) are the most common and characterized anti-phospholipid antibodies (aPL) detected using specific enzyme-linked immunosorbent assay (ELISA) syste
Autor:
Masaru Shibano, Takashi Machii, Yasuhiko Azenishi, Mitsuhiro Yamaguchi, Teruo Kitani, Junichi Nishimura, Yuzuru Kanakura
Publikováno v:
Blood Cells, Molecules, and Diseases. 26:247-254
ABSTRACT To detect a small population of blood cells with a deficiency of glycosyl phosphatidylinositol (GPI)-anchored protein, we evaluated the expression of CD59 by flow cytometry on one million erythrocytes, which is about 100 times more than the
Autor:
Shin-ichiro Kuriya, Isao Maekawa, Nobuyuki Hamajima, Chihiro Shimazaki, Akira Shibata, Makio Wada, Teruo Kitani, Tamotsu Miyazaki, Yoshiyuki Niho, Tsugumichi Kawamura, Yutaka Sato, Hirokuni Taguchi, Hideaki Mizoguchi, Ryuzo Ohno
Publikováno v:
British Journal of Haematology. 109:805-814
This pilot study evaluated the efficacy of a new combination chemotherapy with a newly developed nitrosourea derivative ranimustine and evaluated the efficacy of interferon alpha (IFN-alpha) maintenance in previously untreated patients with multiple